Incidence of multiglandular disease in primary hyperparathyroidism determined by parathyroid hormone secretion

被引:88
作者
Molinari, AS
Irvin, GL
Deriso, GT
Bott, L
机构
[1] UNIV MIAMI,SCH MED,DEPT SURG R310,MIAMI,FL 33101
[2] UNIV MIAMI,JACKSON MEM MED CTR,MIAMI,FL
[3] VET AFFAIRS MED CTR,MIAMI,FL 33125
关键词
D O I
10.1016/S0039-6060(96)80036-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Successful parathyroidectomy depends on recognition and excision of all hyperfunctioning parathyroid glands. Because histologic definition is limited, multiglandular disease (MGD) is usually determined grossly by means of estimation of gland size and the experience of the surgeon, resulting in frequency varying from 8% to 33%. Normalization of elevated intraoperative intact parathyroid hormone (iPTH) levels after excision of all hyperfunctioning glands is necessary for postoperative normocalcemia and indicates normal secretion of remaining parathyroids. Abnormal hormone secretion measured during operation has been used to define the extent of excision and the incidence of MGD. Methods. One hundred ten consecutive parathyroidectomy patients with no previous neck surgery or history of multiple endocrine neoplasia had intraoperative iPTH assays performed before and after excision of any suspected abnormal parathyroid gland(s). A drop in iPTH level after gland excision predicted postoperative normal calcium levels. Results. All patients except one had normalization of serum calcium levels (average follow-up, 15 months). One hundred five patients had only one hyperfunctioning gland removed, and all have remained normocalcemic. Five 5% patients had more than one gland involved: four had two or more hyperfunctioning parathyroids and one patient, who had a large parathyroid cyst removed, remained hypercalcemic. Conclusions. By using a biochemical assay instead of estimated size, to predict which parathyroid glands are hypersecreting the incidence of MGD in primary hyperparathyroidism was found to be 5%.
引用
收藏
页码:934 / 936
页数:3
相关论文
共 14 条
[1]  
ATTIE JN, 1990, SURGERY, V108, P1014
[2]   SINGLE AND MULTIGLAND DISEASE IN PRIMARY HYPERPARATHYROIDISM - CLINICAL FOLLOW-UP, HISTOPATHOLOGY, AND FLOW CYTOMETRIC DNA ANALYSIS [J].
BONJER, HJ ;
BRUINING, HA ;
BIRKENHAGER, JC ;
NISHIYAMA, RH ;
JONES, MA ;
BAGWELL, CB .
WORLD JOURNAL OF SURGERY, 1992, 16 (04) :737-744
[3]   OPERATIVE MONITORING OF PARATHYROID-GLAND HYPERFUNCTION [J].
IRVIN, GL ;
DEMBROW, VD ;
PRUDHOMME, DL .
AMERICAN JOURNAL OF SURGERY, 1991, 162 (04) :299-302
[4]  
IRVIN GL, 1993, SURGERY, V114, P1019
[5]   A NEW, PRACTICAL INTRAOPERATIVE PARATHYROID-HORMONE ASSAY [J].
IRVIN, GL ;
DERISO, GT .
AMERICAN JOURNAL OF SURGERY, 1994, 168 (05) :466-468
[6]  
MALMEUS J, 1988, ACTA CHIR SCAND, V154, P405
[7]  
PROYE CAG, 1992, SURGERY, V112, P1118
[8]  
Rossi RL., 1991, SURGERY THYROID PARA, P283
[9]  
Sfakianakis GN, 1996, J NUCL MED, V37, P798
[10]   CERVICAL EXPLORATION FOR PRIMARY HYPERPARATHYROIDISM [J].
SHAHA, AR ;
JAFFE, BM .
JOURNAL OF SURGICAL ONCOLOGY, 1993, 52 (01) :14-17